SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling
about
Mitochondrial ubiquitin ligase MARCH5 promotes TLR7 signaling by attenuating TANK actionDefects in mucosal immunity leading to Crohn's diseaseSIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanismsThe LIM protein Ajuba influences interleukin-1-induced NF-kappaB activation by affecting the assembly and activity of the protein kinase Czeta/p62/TRAF6 signaling complexA20 is an early responding negative regulator of Toll-like receptor 5 signalling in intestinal epithelial cells during inflammationInterleukin-1 in the pathogenesis and treatment of inflammatory diseasesHomeostasis and inflammation in the intestinePathogen recognition and inflammatory signaling in innate immune defensesNegative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivariusDistinct gene expression profiles in immortalized human urothelial cells exposed to inorganic arsenite and its methylated trivalent metabolitesRegulatory Role of IL-1R8 in Immunity and DiseaseBiomarkers of postoperative delirium and cognitive dysfunctionThe Yin and Yang of Toll-like receptors in cancerTLR-Dependent Human Mucosal Epithelial Cell Responses to Microbial PathogensImmunoregulatory Effects Triggered by Lactic Acid Bacteria Exopolysaccharides: New Insights into Molecular Interactions with Host CellsPathophysiological roles for IL-18 in inflammatory arthritisInterleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKsIL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transductionTriad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptorsNF-kappaB and the immune responseSignal transduction by the lipopolysaccharide receptor, Toll-like receptor-4Role for B-cell adapter for PI3K (BCAP) as a signaling adapter linking Toll-like receptors (TLRs) to serine/threonine kinases PI3K/AktFLN29, a novel interferon- and LPS-inducible gene acting as a negative regulator of toll-like receptor signalingThe ubiquitin-like protein PLIC-1 or ubiquilin 1 inhibits TLR3-Trif signalingThe ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responsesNegative regulation of toll-like receptor-mediated immune responsesThe Role of IL-37 in Non-Cancerous Diseases.The role of IL-37 in cancer.Global analysis of glycoproteins identifies markers of endotoxin tolerant monocytes and GPR84 as a modulator of TNFα expression.The NF-kappaB p50 subunit is protective during intestinal Entamoeba histolytica infection of 129 and C57BL/6 mice.The largely normal response to Toll-like receptor 7 and 9 stimulation and the enhanced expression of SIGIRR by B cells in systemic lupus erythematosus.Highlights of the advances in basic immunology in 2011.Murine models of colorectal cancer.Inhibition of TIR domain signaling by TcpC: MyD88-dependent and independent effects on Escherichia coli virulence.The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxinA novel method for determining microflora composition using dynamic phylogenetic analysis of 16S ribosomal RNA deep sequencing data.Evidence for a DC-specific inhibitory mechanism that depends on MyD88 and SIGIRRA central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response.
P2860
03374e898a4718e3129721e30ef134f2883f663f5aed240697fe302777d6176fdbf7143bce1a7c08769f6d0ae1777c123b23e31b8c2fe39bbf11ff3b838677143f9d29efc37431226b6c1eca4393ed619e82e8d60ab2c6f4aa89ed01b6beec2bb027a116be58db3df09778bdae21ae4e3fef967049e4f7bbc4b33515eb92f0a44a0875b87d2a67fe5ce7f12acf0e039e4d16934ea7c0a83efd19d00128b54f56e43e60c4ccb8ca52572b20126398bd250b51e0b3
P248
Q21131419-94F5FD1C-2E58-4182-A3AE-14C3C6532A93Q22242645-AF37D92A-6210-473B-AB39-9A6A61FEADB9Q24301289-8060B051-202F-4F0F-9222-9ABBC3D32BBAQ24301337-80450865-FE79-4A3E-8ECB-A7D9C16686D7Q24317005-8B53BF50-DCED-489F-8F0F-665A3DA60168Q24606766-C44418BA-0C0C-4F83-91A0-EE4AA4B96ED5Q24613509-C1B6AF8A-A71B-4512-AA9B-A0661F4DE8E7Q24643034-4C608AD3-FAD8-4E2E-BA28-580DA249BF97Q24671928-C92888DC-944D-4DDC-BE84-C5348F7FE24EQ24682955-014267AA-52CB-46C3-92A9-A4FEA933C59AQ25256850-0568A26E-B085-4AF1-98E5-448645E5496FQ26752524-44F5B38F-A0B5-4426-B068-E4C546F064E5Q26830796-11654709-E341-461A-A7E3-95283FF16A4BQ26851526-B17CF246-4ACC-4F52-8437-D45E0A48FB97Q26996513-561A47BA-CA04-418F-9FA8-9771669EEE6EQ28078715-6F4566F4-136E-4392-ABCF-90B9950B52CCQ28187644-32667FD7-BC4E-4E26-8207-28CD8A8D61ABQ28239808-C52265E4-9F6E-45CF-B003-C8FE0DC9FC21Q28258076-B14DAFA6-8C9E-478F-BB88-756898B2D0C0Q28258400-3DD4C76C-9AD7-4BCB-BDB8-F564B95D9313Q28271031-5C05B8DC-D541-48AB-80CA-B35D5D536948Q28283196-F86DB1F9-41C8-462F-B1B4-FF056F85C157Q28591616-7388722A-3DF3-457B-B882-CFA507206138Q28591863-9C745C82-C33C-49EE-916D-9DF4AAD94301Q28592653-68B6D76F-B7CA-438C-BA67-076150E71C09Q29616349-A96A5925-7C1E-4781-AEAF-2E2969310A1EQ29619019-AC55ED2A-57E4-4D47-81CC-51E7931744AAQ30152709-6C1A7BDE-D953-4066-AF36-68D8B5902D84Q30152777-E3BA55FF-BBB5-4422-AA25-DA475A1EFA6AQ30356392-302013DB-85DA-4983-82E3-020BAED2FF02Q30434646-408920A1-E907-4EA2-86F1-AE21CC89A899Q31089201-6A754835-052E-4BF7-AF32-857E829FCC3BQ33577368-4B3CECDB-4817-4A7F-8617-5424C7C8642DQ33640905-76CA90A7-2627-47A4-B629-D10CBB9DEC32Q33707753-140236DA-1408-4C14-80AD-61B50E0BBCFAQ33863111-AC96DA32-704B-40EF-9C5D-4B7B137C3DFCQ33880478-61DF332E-B1C3-4693-82E5-23FAA2638C47Q33884220-DDDBA29D-FD7E-4C3D-BEC2-250A015B49CBQ33921027-A384F384-CC30-4A1B-9654-78945306CE67Q33936725-BCAD1463-663A-44E1-9E91-F351A746EEA5
P2860
SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling
@ast
SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling
@en
SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling
@en-gb
SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling
@nl
type
label
SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling
@ast
SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling
@en
SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling
@en-gb
SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling
@nl
prefLabel
SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling
@ast
SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling
@en
SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling
@en-gb
SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling
@nl
P2093
P2860
P921
P3181
P356
P1433
P1476
SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling
@en
P2093
David Wald
George R Stark
Jennifer Towne
Jinzhong Qin
Liping Tian
Xiaoxia Li
Youcun Qian
Zhendong Zhao
P2860
P304
P3181
P356
10.1038/NI968
P407
P577
2003-08-17T00:00:00Z